Heterodimeric IL-15 regulates the balance of effector and regulatory cells, promoting anti-cancer tumor effects

被引：0
|
作者：
Felber, Barbara [1 ]
Bergamaschi, Cristina [1 ]
Ng, Sin Man [1 ]
Chen, Stephanie [1 ]
Bear, Jenifer [1 ]
Alicea, Candido [1 ]
Beach, Rachel Kelly [1 ]
Chertova, Elena [2 ]
Sowder, Raymond [2 ]
Pavlakis, George [1 ]
机构：
[1] NCI, Ctr Canc Res, Frederick, MD 21701 USA
[2] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD USA
来源：
JOURNAL OF IMMUNOLOGY | 2015年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
CCR4P.213
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Heterodimeric IL-15 regulates the balance of effector and regulatory cells, favoring anti-tumor responses
    Bergamaschi, Cristina
    Chen, Stephanie
    Valentin, Antonio
    Kulkarni, Viraj
    Bear, Jenifer
    Rosati, Margherita
    Alicea, Candido
    Beach, Rachel Kelly
    Sowder, Raymond
    Chertova, Elena
    Felber, Barbara K.
    Pavlakis, George N.
    CYTOKINE, 2013, 63 (03) : 247 - 248
  • [2] Heterodimeric IL-15 promotes tumor control through the regulation of the balance of effector and regulatory cells via an IL-2 deprivation mechanism
    Bergamaschi, Cristina
    Ng, Sin-Man
    Chen, Stephanie
    Bear, Jenifer
    Alicea, Candido
    Beach, Rachel K.
    Sowder, Raymond
    Chertova, Elena
    Felber, Barbara K.
    Pavlakis, George N.
    CYTOKINE, 2014, 70 (01) : 29 - 30
  • [3] Treatment with heterodimeric IL-15 promotes effector T cell infiltration into several tumor types
    Bergarnaschi, Cristina
    Dimas, Konstantinos
    Nagy, Bethany
    Jensen, Shawn M.
    Fox, Bernard A.
    Felber, Barbara K.
    Pavlakis, George N.
    CYTOKINE, 2017, 100 : 180 - 181
  • [4] HETERODIMERIC IL-15 ENHANCES TUMOR INFILTRATION, PERSISTENCE AND EFFECTOR FUNCTIONS OF ADOPTIVELY TRANSFERRED TUMOR-SPECIFIC T CELLS IN THE ABSENCE OF LYMPHODEPLETION
    Bergamaschi, C.
    Ng, S. S. M.
    Nagy, B. A.
    Jensen, S. M.
    Hui, X.
    Alicea, C.
    Fox, B. A.
    Felber, B. K.
    Pavlakis, G. N.
    CYTOKINE, 2016, 87 : 93 - 94
  • [5] Heterodimeric IL-15 enhances tumor infiltration, persistence and effector functions of adoptively transferred tumor-specific T cells in the absence of lymphodepletion
    Ng, Sinnie
    Bergamaschi, Cristina
    Nagy, Bethany
    Alicea, Candido
    Jensen, Shawn M.
    Fox, Bernard A.
    Felber, Barbara K.
    Pavlakis, George N.
    CANCER RESEARCH, 2016, 76
  • [6] The balance of effector and regulatory cell populations in oral chronic GVHD: Potential role of IL-15
    Imanguli, Matin
    Hakim, Frances
    Swaim, William
    Guadagnini, Jean-Pierre
    League, Stacy
    Gress, Ronald
    Pavletic, Steven
    BLOOD, 2007, 110 (11) : 321A - 321A
  • [7] Il-15 an immunoregulatory and anti-cancer cytokine. Recent advances
    Shanmugham, L. N.
    Petrarca, C.
    Frydas, S.
    Donelan, J.
    Castellani, M. L.
    Boucher, W.
    Madhappan, B.
    Tete, S.
    Falasca, K.
    Conti, P.
    Vecchiet, J.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2006, 25 (04) : 529 - 536
  • [8] Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer
    Morris, J. C.
    Ramlogan-Steel, C. A.
    Yu, P.
    Black, B. A.
    Mannan, P.
    Allison, J. P.
    Waldmann, T. A.
    Steel, J. C.
    GENE THERAPY, 2014, 21 (04) : 393 - 401
  • [9] IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM)
    Wege, A. K.
    Weber, F.
    Ortmann, O.
    Nimmerjahn, F.
    Brockhoff, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 176 - 176
  • [10] IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM)
    Wege, Anja K.
    Weber, Florian
    Kroemer, Alexander
    Ortmann, Olaf
    Nimmerjahn, Falk
    Brockhoff, Gero
    ONCOTARGET, 2017, 8 (02) : 2731 - 2744
12345